Home › Atrial Fibrillation › Washington › Seattle
Atrial Fibrillation clinical trials in Seattle, WA
5 studies for Atrial Fibrillation are looking for participants at sites in and around Seattle (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation
RecruitingPhase 2
- Swedish Heart and Vascular Clinic, Seattle
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
RecruitingObservational study
- University of Washington-Seattle, Seattle
Medtronic Terminate AF Study
Recruiting
- Virginia Mason Heart Institute, Seattle
- Swedish Medical Center, Seattle
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
RecruitingPhase 3
- Harborview Medical Center, Seattle
Sleep Apnea Triggers of Atrial Fibrillation: N-of-1 Randomized Control Trial (SPARTA):
Recruiting
- University of Washington, Seattle
About Atrial Fibrillation
Atrial fibrillation (AF or AFib) is the most common type of arrhythmia (irregular heartbeat). Read about symptoms and treatment.
More about Atrial Fibrillation on MedlinePlus
Atrial Fibrillation trials in other cities
- New York City, NY21 studies
- Boston, MA17 studies
- Cleveland, OH17 studies
- Atlanta, GA16 studies
- Philadelphia, PA12 studies
- Jonesboro, AR12 studies
- Chicago, IL12 studies
- Ann Arbor, MI11 studies
- Cincinnati, OH10 studies
- Pittsburgh, PA10 studies
- Columbus, OH10 studies
- New Orleans, LA9 studies
Other studies in Seattle
- Non-Small Cell Lung Cancer53 studies
- Cancer (all types)50 studies
- Prostate Cancer44 studies
- Acute Myeloid Leukemia40 studies
- Breast Cancer40 studies
- Metastatic Cancer39 studies
- Colorectal Cancer34 studies
- Lung Cancer33 studies
- Ovarian Cancer31 studies
- Pancreatic Cancer22 studies
- Multiple Myeloma22 studies
- Acute Lymphoblastic Leukemia21 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.